THC Cross-Tolerance to Barbiturates Was Much Smaller Than THC Tolerance in Pigeons

Pigeons exposed to THC for six weeks showed cross-tolerance to two barbiturates on an operant task, but the shifts were much smaller than tolerance to THC itself. Cross-tolerance was also not equally evident in every bird for both drugs.

The endpoint was food-maintained responding

Six pigeons responded under a variable-interval food schedule. Researchers measured pentobarbital and barbital dose-effect curves before and during chronic THC administration. This was a behavioral pharmacology task, not an evaluation of human sedation or safe drug combinations.

Group and individual findings differed

Both barbiturate curves shifted significantly rightward, consistent with reduced sensitivity on the task. All six birds showed pentobarbital tolerance, while four showed barbital tolerance. The large THC tolerance therefore did not imply a comparably large or universally expressed cross-drug effect.

Barbital added a mechanistic comparison

The authors emphasized that cross-tolerance could occur with a barbiturate that normally undergoes little metabolism. That observation challenges an exclusively metabolic explanation but does not fully identify the responsible neural adaptation. The supplied abstract's blood-level passage is incomplete, so a more detailed pharmacokinetic result is not asserted here.

This historical experiment supports selective cross-drug generalization after repeated THC. It cannot establish tolerance to every sedative or translate pigeon potency shifts into human doses. The relative magnitude, individual variation and specific operant endpoint are more informative than a broad claim of barbiturate resistance.

Related: interpreting cannabis tolerance claims.

Research cited

Chait LD; Brocco MJ; McMillan DE. Effects of chronic delta 9-tetrahydrocannabinol administration on schedule-controlled behavior of pigeons: cross-tolerance to pentobarbital and barbital. Psychopharmacology (1981). doi:10.1007/BF00433491. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A 2026 Cannabis Review Explains Why Potency, Placebo Response and Sedation Need Separate Measures

A 2026 narrative review argues that product potency is not the same as delivered THC dose and that placebo responses remain important among experienced users. Its laboratory framework also distinguishes reduced drug reinforcement from nonspecific sedation. Users can change how they inhale The review notes that participants alter inhalation patterns…

Spread the love

Read Article: A 2026 Cannabis Review Explains Why Potency, Placebo Response and Sedation Need Separate Measures

THC Antinociception Persisted Without the Same Dynorphin Signal in Tolerant Rats

A 1999 rat study found that tolerance weakened THC-related modulation of spinal dynorphin, while antinociception could still occur without the same elevated dynorphin measure. The role of a downstream signal changed with dose and adaptive state. The experiment examined spinal responses The work followed earlier findings linking acute intrathecal THC…

Spread the love

Read Article: THC Antinociception Persisted Without the Same Dynorphin Signal in Tolerant Rats

A Passiflora-Derived Fraction Reduced THC Withdrawal Signs in a Mouse Model

A 2002 mouse experiment reported fewer antagonist-precipitated withdrawal signs with a Passiflora-derived benzoflavone fraction. The finding concerns a defined experimental preparation and animal model, not a demonstrated treatment for cannabis-use disorder in people. Concurrent and acute interventions were tested Mice received repeated oral THC with or without the fraction. A…

Spread the love

Read Article: A Passiflora-Derived Fraction Reduced THC Withdrawal Signs in a Mouse Model

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us